Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunity
Programmed cell death protein 1 (PD-1) inhibitors are a common treatment strategy for metastatic melanoma and other tumour entities. Clinical trials u…
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 February 2017
|
| In: |
European journal of cancer
Year: 2017, Volume: 75, Pages: 24-32 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2016.12.038 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2016.12.038 Verlag, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804917300576 
|
| Author Notes: | Ralf Gutzmer, Anika Koop, Friedegund Meier, Jessica C. Hassel, Patrick Terheyden, Lisa Zimmer, Lucie Heinzerling, Selma Ugurel, Claudia Pfohler, Anja Gesierich, Elisabeth Livingstone, Imke Satzger, Katharina C. Kähler |
| Summary: | Programmed cell death protein 1 (PD-1) inhibitors are a common treatment strategy for metastatic melanoma and other tumour entities. Clinical trials u… |
|---|---|
| Item Description: | Gesehen am 23.08.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2016.12.038 |